Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 9, 2018Clinical Journal of the American Society of NephrologyOpen Access

Chimeric Antigen Receptor T Cell Therapy and the Kidney

View Full Paper
Ask AI
Bookmark
Share

Authors

KJKenar D. JhaveriNorthwell HealthMRMitchell H. RosnerUniversity of Virginia Health System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jhaveri et al. (2018) studied this question.

synapsesocial.com/papers/69db25b01e19c8ae08836c26https://doi.org/10.2215/cjn.12871117
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia2016 · 222 citations
  2. 2Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia2013 · 3,530 citations
  3. 3Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia2016 · 461 citations
  4. 4Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia2014 · 5,505 citations
  5. 5Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia2011 · 3,593 citations